CDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAFV600 Melanoma via a p53 Dependent Pathway
Nancy T. Santiappillai(The University of Melbourne), Lorey Smith(Peter MacCallum Cancer Centre)
Cited by 35
Related Papers
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAFV600 melanoma
|Nature Communications|2022|29